Fabrication and Characterization of 3D Printed Polycaprolactone/Baghdadite/Zinc Oxide Nanocomposite Scaffolds for Bone Tissue Engineering
Abstract
Nowadays, the use of 3D printing method in the construction of scaffolds is significantly common for bone tissue engineering applications. Moreover, the addition of nanoparticles and additives can significantly improve the mechanical and biological properties of polymeric scaffolds as polymers alone are not able to show enough performances. In this study, composite scaffolds based on polycaprolactone (PCL) containing different amounts of zinc oxide (ZnO) and Baghdadite (B) nanoparticles were fabricated by 3D printing method as novel combinations for bone tissue engineering. Then, their physical, mechanical, and biological properties were investigated. The scanning electron microscopy (SEM) of the composite showed uniform and porous structures with open porosity. Fourier-transform infrared spectroscopy (FTIR) of the scaffolds confirmed that no reaction occurred between PCL, B, and ZnO nanoparticles during the fabrication of composite scaffolds. The PCL/B/ZnO composite scaffolds showed high compressive strength. They also showed weight loss during 4 weeks, which was related to PCL degradation. The high bioactivity of the composite scaffolds was confirmed by dispersive X-ray analysis (EDS). SEM images showed the formation of calcium phosphate (CaP) layer on scaffolds in simulated body fluid (SBF). Inductively coupled plasma (ICP) analysis confirmed the formation of apatite layer on their surfaces. Based on the results of the (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.